Non-caloric Sweeteners Levels in Breast Milk and Newborn's Blood and Effect on Microbiota's Composition.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Mexico City, Mexico, 06726
- General Hospital of Mexico Dr. Eduardo Liceaga
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18-40 years old
- Women in labor
- Consent to participate in the study
Exclusion Criteria:
- Pre-term delivery (<30 weeks)
- Metabolic diseases (insulin resistance, diabetes, gestational diabetes)
- Hypertension
- Thyroid disease
- Cancer
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Null or low consumption
No-intervention.
The group consists of women who have reported a null or low consumption of non-caloric sweeteners during late pregnancy.
|
No intervention
|
|
Moderate consumption
No-intervention.
The group consists of women who have reported a moderate consumption of non-caloric sweeteners during late pregnancy.
|
No intervention
|
|
High consumption
No-intervention.
The group consists of women who have reported a high consumption of non-caloric sweeteners during late pregnancy.
|
No intervention
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microbiota composition in feces
Time Frame: 2 months
|
Composition of feces microbiota in mother and newborn
|
2 months
|
|
Microbiota composition in feces
Time Frame: 4 months
|
Composition of feces microbiota in mother and newborn
|
4 months
|
|
Microbiota composition in feces
Time Frame: 6 months
|
Composition of feces microbiota in mother and newborn
|
6 months
|
|
Microbiota composition in breast milk
Time Frame: 0 months
|
Composition of breast milk microbiota
|
0 months
|
|
Microbiota composition in breast milk
Time Frame: 2 months
|
Composition of breast milk microbiota
|
2 months
|
|
Microbiota composition in breast milk
Time Frame: 4 months
|
Composition of breast milk microbiota
|
4 months
|
|
Microbiota composition in breast milk
Time Frame: 6 months
|
Composition of breast milk microbiota
|
6 months
|
|
Non-caloric sweeteners levels at birth
Time Frame: at birth
|
Non-caloric sweeteners levels in milk, plasma, umbilical cord plasma, urine in mg/mL
|
at birth
|
|
Non-caloric sweeteners levels 2 months follow-up
Time Frame: 2 months after birth
|
Non-caloric sweeteners levels in breast milk and urine in the 2 months follow-up
|
2 months after birth
|
|
Non-caloric sweeteners levels 4 months follow-up
Time Frame: 4 months after birth
|
Non-caloric sweeteners levels in breast milk and urine in the 4 months follow-up
|
4 months after birth
|
|
Non-caloric sweeteners levels 6 months follow-up
Time Frame: 6 months after birth
|
Non-caloric sweeteners levels in breast milk and urine in the 6 months follow-up
|
6 months after birth
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Marcela Esquivel, PhD, Hospital General de México Dr. Eduardo Liceaga
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DI/17/301/05/075
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.